MYOCARDIAL CATECHOLAMINE CONTENT IN HEART-FAILURE .2. MEASUREMENTS IN ENDOMYOCARDIAL BIOPSIES, REFERENCE SYSTEM, NORMAL VALUES

  • 1 December 1989
    • journal article
    • research article
    • Vol. 78  (12) , 759-763
Abstract
To enable the assessment of a possible gradual loss of myocardial catecholamines in heart failure, we determined control values in endomyocardial biopsies from normal human right ventricular myocardium. The reproducibility of the determinations and its dependence on the reference system, we weight (wwt) or non-collagen-protein (NCP), was investigated in explanted hearts. Parallel determinations of norepinephrine in several samples from 1-2 mg in the same heart yielded a variaibility of about 20%. To obtain reproducible values, catecholamine concentrations had to be related to non-collagen-protein. Non-collagen-protein content was higher in the ventricles (138 .+-. 16 .mu.g/mg wwt) than in the atria (102 .+-. 15 .mu.g/mg wwt). Norepinehprine levels in normal human myocardium, measured in right ventricular endomyocardial biopsies were 10.3 .+-. 3 pg/.mu.g NCP. If they were compared with norepinephrine levels in right atrial samples from 11 patients without heart failure, obtained at open heart surgery (17.6 .+-. 6 pg/.mu.g NCP), an atrioventricular gradient, with ventricular norepinephrine content being 58% of right atrial levels was calculated for healthy human hearts. This gradient was almost identical with that found in heart-failure patients, where right ventricular norepinephrine amounted to 60% of right atrial levels. This implicates a percentually homogeneous loss of norepinephrine in heart failure, which, however, does not equalize ventricular and atrial levels. Thus, to interpret myocardial catecholamine content in cardiac disease, normal values in corresponding areas are mandatory.

This publication has 0 references indexed in Scilit: